Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China
· Delayed Price · Currency is CNY 30.88
+0.52 (1.71%)
Apr 29, 2026, 4:00 PM EDT
SHE:301166 Revenue
Shanghai Universal Biotech had revenue of 259.31M CNY in the quarter ending March 31, 2026, a decrease of -10.59%. This brings the company's revenue in the last twelve months to 1.07B, down -8.67% year-over-year. In the year 2024, Shanghai Universal Biotech had annual revenue of 1.12B, down -8.82%.
Revenue (ttm)
1.07B
Revenue Growth
-8.67%
P/S Ratio
2.48
Revenue / Employee
1.63M
Employees
698
Market Cap
2.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.12B | -108.07M | -8.82% |
| Dec 31, 2023 | 1.23B | 30.70M | 2.57% |
| Jan 1, 2023 | 1.20B | 85.46M | 7.70% |
| Jan 1, 2022 | 1.11B | 260.59M | 30.69% |
| Dec 31, 2020 | 849.08M | 62.15M | 7.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cabio Biotech (Wuhan) | 418.18M |
| Suzhou Fushilai Pharmaceutical | 412.51M |
| Jilin Jian Yisheng Pharmaceutical | 659.66M |
| Hubei Goto Biopharm | 606.18M |
| Shanghai Hile Bio-Technology | 246.35M |
| Shandong Sito Bio-technology | 954.76M |
| Zhejiang East Asia Pharmaceutical | 940.19M |
| Jiangsu Sihuan Bioengineering | 381.71M |